Showing results (171-180 of 321) with videos related to
Sort By:
Pageof 33
Arthritis Research & Therapy|February 21, 2021
Macrophage migration inhibitory factor may play a protective role in osteoarthritisMing Liu, Zikun Xie, Guang Sun, et al.Pain|August 25, 2020
Metabolomic analysis coupled with extreme phenotype sampling identified that lysophosphatidylcholines are associated with multisite musculoskeletal painMing Liu, Zikun Xie, Christie A Costello, et al.International Journal of Population Data Science|August 31, 2023
Laying the foundation for Real-world evidence studies: a case study from Newfoundland and LabradorWinifred Badaiki, Evelyn Pyper, Kendra Lester, et al.Arthritis Research & Therapy|April 29, 2023
Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?Walter P Maksymowych, Robert D Inman, Louis Bessette, et al.The Journal of Rheumatology|June 1, 2023
Real-World Incidence and Determinants of Infection in Patients With Rheumatoid Arthritis Treated With Golimumab After a Median Follow-Up Time of 27 MonthsLouis Bessette, Proton Rahman, John Kelsall, et al.Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|March 9, 2026
Suggestive Association Between Tryptophan-indole Metabolic Pathway and Total Joint Arthroplasty Early Revision for Heterogeneous Failure Modes in Patients With Primary Osteoarthritis: A Meta-analysis of MetabolomicsMing Liu, Robert Gill, Rajiv Gandhi, et al.Arthritis and Rheumatism|April 1, 2009
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled studyArthur Kavanaugh, Iain McInnes, Philip Mease, et al.Journal of Cutaneous Medicine and Surgery|February 12, 2019
Treating to Target(s) With Interleukin-17 InhibitorsCharles W Lynde, Jennifer Beecker, Jan Dutz, et al.Patient Preference and Adherence|June 30, 2025
Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational StudyLouis Bessette, Pauline Boulos, Regan Arendse, et al.BMC Rheumatology|September 20, 2021
Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week resultsAtul A Deodhar, Philip J Mease, Proton Rahman, et al.Pageof 33